Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
October-2019 Volume 42 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2019 Volume 42 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article

Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway

  • Authors:
    • Qingkai Zhang
    • Fenglin Hu
    • Fangyue Guo
    • Qi Zhou
    • Hong Xiang
    • Dong Shang
  • View Affiliations / Copyright

    Affiliations: Department of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China, Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Clinical Laboratory of Integrative Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China
  • Pages: 1589-1597
    |
    Published online on: August 8, 2019
       https://doi.org/10.3892/or.2019.7270
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute pancreatitis (AP) is an inflammatory disease with high morbidity and mortality rates. Pancreatic ductal cells are the most susceptible of all cell types that are exposed to the noxious stimuli of pancreatitis. Our previous studies demonstrated that emodin, a natural product extracted from Rheum palmatum L., protected pancreatic acinar cells from injutyh due to its anti‑inflammatory activity. In the present study, in order to investigate the protective effects and molecular mechanisms of action of emodin on injured pancreatic ductal cells, an adenosine triphosphate (ATP)‑induced model of cell injury was established using the human pancreatic ductal epithelial cell line, HPDE6‑C7. The results revealed that emodin attenuated ATP‑induced HPDE6‑C7 cell injury by decreasing the levels of inflammatory factors, including interleukin (IL)‑1β and IL‑18. Furthermore, emodin significantly downregulated the protein levels of purinergic receptor P2X, ligand‑gated ion channel, 7 (P2X7), NOD‑like receptor protein 3 (NLRP3), apoptosis‑associated speck‑like protein containing a CARD (ASC) and caspase‑1 in the injured HPDE6‑C7 cells. The results also indicated that emodin attenuated HPDE6‑C7 cell injury at least partially through the inhibition of the P2X7/NLRP3 signaling pathway. The protective effects of emodin were abrogated upon pre‑treatment with P2X7 overexpression plasmid, which further confirmed that the P2X7 signaling pathway is the drug target of the effects of emodin against ATP‑induced pancreatic ductal cell injury. Collectively, the findings of this study demonstrate that emodin attenuates ATP‑induced pancreatic ductal cell injury in AP mainly through the inhibition of the P2X7/NLRP3 signaling pathway. This study suggests that emodin may be further developed for its application in future medical therapy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Lankisch PG, Apte M and Banks PA: Acute pancreatitis. Lancet. 386:85–96. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Manohar M, Verma AK, Venkateshaiah SU, Sanders NL and Mishra A: Pathogenic mechanisms of pancreatitis. World J Gastrointest Pharmacol Ther. 8:10–25. 2017. View Article : Google Scholar : PubMed/NCBI

3 

O'Reilly DA and Kingsnorth AN: A brief history of pancreatitis. J R Soc Med. 94:130–132. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Zhou Q, Xia S, Guo F, Hu F, Wang Z, Ni Y, Wei T, Xiang H and Shang D: Transforming growth factor-β in pancreatic diseases: Mechanisms and therapeutic potential. Pharmacol Res. 142:58–69. 2019. View Article : Google Scholar : PubMed/NCBI

5 

Blanchard JN II, Barve S, Joshi-Barve S, Talwalker R and Gates LK Jr: Cytokine production by CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci. 45:927–932. 2000. View Article : Google Scholar : PubMed/NCBI

6 

Neoptolemos JP, London NJ and Carr-Locke DL: Assessment of main pancreatic duct integrity by endoscopic retrograde pancreatography in patients with acute pancreatitis. Br J Surg. 80:94–99. 1993. View Article : Google Scholar : PubMed/NCBI

7 

Wen L, Javed TA, Yimlamai D, Mukherjee A, Xiao X and Husain SZ: Transient high pressure in pancreatic ducts promotes inflammation and alters tight junctions via calcineurin signaling in mice. Gastroenterology. 155:1250–1263.e5. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Venglovecz V, Rakonczay Z Jr, Gray MA and Hegyi P: Potassium channels in pancreatic duct epithelial cells: Their role, function and pathophysiological relevance. Pflugers Arch. 467:625–640. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Xiang H, Zhang QK, Qi B, Tao XF, Xia SL, Song HY, Qu JL and Shang D: Chinese herbal medicines attenuate acute pancreatitis: Pharmacological activities and mechanisms. Front Pharmacol. 8:2162017. View Article : Google Scholar : PubMed/NCBI

10 

Hegyi P and Petersen OH: The exocrine pancreas: The acinar-ductal tango in physiology and pathophysiology. Rev Physiol Biochem Pharmacol. 165:1–30. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Novak I, Haanes KA and Wang J: Acid-base transport in pancreas-new challenges. Front Physiol. 4:3802013. View Article : Google Scholar : PubMed/NCBI

12 

Blanchard JN II, Blanchard JA, Barve S, Joshi-Barve S, Talwalker R and Gates LK Jr: Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci. 46:2768–2772. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Wen L, Voronina S, Javed MA, Awais M, Szatmary P, Latawiec D, Chvanov M, Collier D, Huang W, Barrett J, et al: Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of human pancreatic acinar cells and acute pancreatitis in 3 mouse models. Gastroenterology. 149:481–492.e7. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Mrazek AA, Bhatia V, Falzon M, Spratt H, Chao C and Hellmich MR: Apigenin decreases acinar cell damage in pancreatitis. Pancreas. 48:711–718. 2019. View Article : Google Scholar : PubMed/NCBI

15 

Kong L, Wu Q, Zhao L, Ye J, Li N and Yang H: Effect of microRNA-27a-5p on apoptosis and inflammatory response of pancreatic acinar cells in acute pancreatitis by targeting PTEN. J Cell Biochem. 120:15844–15850. 2019.PubMed/NCBI

16 

Novak I, Jans IM and Wohlfahrt L: Effect of P2X(7) receptor knockout on exocrine secretion of pancreas, salivary glands and lacrimal glands. J Physiol. 588:3615–3627. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Henriksen KL and Novak I: Effect of ATP on intracellular pH in pancreatic ducts involves P2X7 receptors. Cell Physiol Biochem. 13:93–102. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Hoque R, Sohail M, Malik A, Sarwar S, Luo Y, Shah A, Barrat F, Flavell R, Gorelick F, Husain S and Mehal W: TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology. 141:358–369. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Giuliani AL, Sarti AC, Falzoni S and Di Virgilio F: The P2X7 receptor-interleukin-1 liaison. Front Pharmacol. 8:1232017. View Article : Google Scholar : PubMed/NCBI

20 

Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, Fellin R, Trabace L and Di Virgilio F: Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J Immunol. 182:4378–4385. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Zhu S, Wang Y, Wang X, Li J and Hu F: Emodin inhibits ATP-induced IL-1β secretion, ROS production and phagocytosis attenuation in rat peritoneal macrophages via antagonizing P2X7 receptor. Pharm Biol. 52:51–57. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Xu H, Xiong C, He L, Wu B, Peng L, Cheng Y, Jiang F, Tan L, Tang L, Tu Y, et al: Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: Possible role of P38 MAPK pathway. Inflammation. 38:327–337. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Chen Q, Wu H, Qin S, Liu C, Chen Y, Yang Y and Xu C: The P2X7 receptor involved in gp120-induced cell injury in BV2 microglia. Inflammation. 39:1814–1826. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Yuan BS, Zhu RM, Braddock M, Zhang XH, Shi W and Zheng MH: Interleukin-18: A pro-inflammatory cytokine that plays an important role in acute pancreatitis. Expert Opin Ther Targets. 11:1261–1271. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Dong X, Fu J, Yin X, Cao S, Li X, Lin L and Huyiligeqi Ni J: Emodin: A review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 30:1207–1218. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Xiang H, Tao X, Xia S, Qu J, Song H, Liu J and Shang D: Emodin alleviates sodium taurocholate-induced pancreatic acinar cell injury via MicroRNA-30a-5p-mediated inhibition of high-temperature requirement a/transforming growth factor beta 1 inflammatory signaling. Front Immunol. 8:14882017. View Article : Google Scholar : PubMed/NCBI

27 

Zhou Q and Melton DA: Pancreas regeneration. Nature. 557:351–358. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Kowal JM, Yegutkin GG and Novak I: ATP release, generation and hydrolysis in exocrine pancreatic duct cells. Purinergic Signal. 11:533–550. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Novak I, Nitschke R and Amstrup J: Purinergic receptors have different effects in rat exocrine pancreas. Calcium signals monitored by fura-2 using confocal microscopy. Cell Physiol Biochem. 12:83–92. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Burnstock G and Novak I: Purinergic signalling in the pancreas in health and disease. J Endocrinol. 213:123–141. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z and Zhou R: Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 160:62–73. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Li X and Zhong F: Nickel induces interleukin-1β secretion via the NLRP3-ASC-caspase-1 pathway. Inflammation. 37:457–466. 2014. View Article : Google Scholar : PubMed/NCBI

33 

de Torre-Minguela C, Mesa Del Castillo P and Pelegrin P: The NLRP3 and pyrin inflammasomes: Implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 8:432017. View Article : Google Scholar : PubMed/NCBI

34 

Wen H, Miao EA and Ting JP: Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity. 39:432–441. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Q, Hu F, Guo F, Zhou Q, Xiang H and Shang D: Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway. Oncol Rep 42: 1589-1597, 2019.
APA
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., & Shang, D. (2019). Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway. Oncology Reports, 42, 1589-1597. https://doi.org/10.3892/or.2019.7270
MLA
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., Shang, D."Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway". Oncology Reports 42.4 (2019): 1589-1597.
Chicago
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., Shang, D."Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway". Oncology Reports 42, no. 4 (2019): 1589-1597. https://doi.org/10.3892/or.2019.7270
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q, Hu F, Guo F, Zhou Q, Xiang H and Shang D: Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway. Oncol Rep 42: 1589-1597, 2019.
APA
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., & Shang, D. (2019). Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway. Oncology Reports, 42, 1589-1597. https://doi.org/10.3892/or.2019.7270
MLA
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., Shang, D."Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway". Oncology Reports 42.4 (2019): 1589-1597.
Chicago
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., Shang, D."Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathway". Oncology Reports 42, no. 4 (2019): 1589-1597. https://doi.org/10.3892/or.2019.7270
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team